Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, and COVID-19 and healthcare impacts.
Tackling the next decade of cancer research
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Dual-Targeted Therapy with Ruxolitinib Plus Duvelisib for T-Cell Lymphoma
Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin
Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cells
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence
SARS-CoV-2 in immunocompromised individuals
A Novel Microbiome Signature in Gastric Cancer
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies
Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease
The many faces of the anti-COVID immune response
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
Glutamine independence is a selectable feature of pluripotent stem cells
Leveraging insights into cancer metabolism—a symposium report
Self-reactive human CD4 T cell clones form unusual immunological synapses
T Lymphocyte Myosin IIA is Required for Maturation of the Immunological Synapse